About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Gastroenterology and Hepatology
›
top-articles
Department of Gastroenterology and Hepatology
17
(top 2%)
papers
143
(top 5%)
citations
7
(top 5%)
h
-index
12
(top 5%)
g
-index
17
all documents
170
doc citations
89
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
Journal of Autoimmunity
2021
41
2
Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature
Scandinavian Journal of Gastroenterology
2021
36
3
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis
Digestive and Liver Disease
2022
17
4
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
Gut
2021
13
5
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases – A Danish Prospective Population-Based Cohort Study with Individual-Level Data
Journal of Crohn's and Colitis
2022
13
6
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases
Scandinavian Journal of Gastroenterology
2021
12
7
Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study
European Journal of Gastroenterology and Hepatology
2021
11
8
Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study
Inflammatory Bowel Diseases
2021
10
9
Home parenteral support in patients with incurable cancer. Patient characteristics of importance for catheter related complications and overall survival
Clinical Nutrition ESPEN
2018
8
10
Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis
Inflammatory Bowel Diseases
2022
5
11
Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
BMJ Open
2022
3
12
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019—A Population-based Study
Inflammatory Bowel Diseases
2022
1
13
P102 Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study
Journal of Crohn's and Colitis
2021
0
14
Authors’ Reply to: ‘COVID-19 in the IBD Population: The Need for Correct Nomenclature’
Journal of Crohn's and Colitis
2021
0
15
DOP10 Intestinal Ultrasound at IBD diagnosis predicts major disease events – A Copenhagen IBD cohort study
Journal of Crohn's and Colitis
2022
0
16
P520 Very early intestinal ultrasound predicts intravenous corticosteroid failure in hospitalized severe ulcerative colitis patients
Journal of Crohn's and Colitis
2022
0
17
P639 Incidence and disease presentation of inflammatory bowel disease in Denmark: initial findings from a Copenhagen IBD Inception Cohort Study
Journal of Crohn's and Colitis
2022
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.